Recent data presented at Digestive Disease Week 2014 revealed that less than half of the patients who show indications of celiac disease are being properly screened. An article in Gastroenterology & Endoscopy News notes that current celiac screening guidelines set by national organizations are not being followed routinely.
The current best practice is for celiac screening in patients with chronic gastrointestinal symptoms including postprandial abdominal pain, chronic diarrhea, or steatorrhea. The study, which was conducted at Washington University in St. Louis, analyzed the medical records of all patients in the university’s GI center. Slightly over half of the patients evaluated had indications of celiac disease consistent with the screening guidelines. Of those with indications, less than half received any screening for celiac. Of those who did receive screening, two cases of celiac disease were confirmed. The data suggest that at least another two patients could’ve been identified with proper screening practices.
Celiac disease presents itself symptomatically in varied ways, making it difficult to identify without proper screening procedure. While the guidelines currently in place seem sufficient, they must be followed routinely to be effective.
A similar gastrointestinal condition called sprue-like enteropathy has been associated with use of Benicar, a prescription medication for high blood pressure. This condition can cause severe intestinal issues such as chronic diarrhea, vomiting, and excessive weight loss. This condition can be misdiagnosed as celiac disease and can cause major permanent damage and severely inhibit the lifestyle of its patients.
The attorneys at Lopez McHugh are handling litigation regarding GI effects of Benicar. A Lopez McHugh lawyer can evaluate your potential Benicar lawsuit, free of charge. Contact us today at (877) 737-8525 to schedule a free consultation or simply complete our online contact form.
